Pharmsynthez's latest marketcap:
As of 08/11/2025, Pharmsynthez's market capitalization has reached $18.88 M. According to our data, Pharmsynthez is the 37129th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 18.88 M |
| Revenue (ttm) | 4.33 M |
| Net Income (ttm) | -3,819,801.12 |
| Shares Out | 301.01 M |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/26/2025 |
Pharmsynthez's yearly market capitalization.
| Date | Market Cap(₽) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/08/2022 | ₽1.36 B | $18.32 M | -19.7% | 33118 |
| 12/30/2021 | ₽1.69 B | $22.39 M | -18.1% | 32152 |
| 12/30/2020 | ₽2.06 B | $27.75 M | 65.06% | 27907 |
| 12/30/2019 | ₽1.25 B | $20.1 M | -25.63% | 26374 |
| 12/29/2018 | ₽1.68 B | $24.09 M | -53.5% | 24650 |
| 12/29/2017 | ₽3.61 B | $62.45 M | 44.29% | 20410 |
| 12/30/2016 | ₽2.5 B | $40.53 M | 52.78% | 20362 |
| 12/30/2015 | ₽1.64 B | $22.65 M | -14.96% | 21595 |
| 12/30/2014 | ₽1.93 B | $31.62 M | 19329 |
Company Profile
Public Joint-Stock Company "Pharmsynthez", a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries.
The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis.
Public Joint-Stock Company "Pharmsynthez" was founded in 1996 and is based in St. Petersburg, Russia.
Frequently Asked Questions
-
What is Pharmsynthez's (MOEX-LIFE) current market cap?As of 08/11/2025, Pharmsynthez (including the parent company, if applicable) has an estimated market capitalization of $18.88 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Pharmsynthez (MOEX-LIFE) rank globally by market cap?Pharmsynthez global market capitalization ranking is approximately 37129 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.